Priaxon appoints Dr Constance Hoefer as Chief Development Officer Priaxon appoints Dr Constance Hoefer as Chief Development Officer Brings the necessary experience and knowledge for the Company to successfully advance Priaxon AG’s non-clinical programs towards the clinic Tim Tasker joins Heptares as Chief Medical Officer Tim Tasker joins Heptares as Chief Medical Officer Increases focus on clinical development of GPCR-targeted drug candidates Thomas Broeer elected as new BGMA Chairman Thomas Broeer elected as new BGMA Chairman Brings more than 20 years of industry experience to the position KaloBios hires Harry Lam as Head of Manufacturing KaloBios hires Harry Lam as Head of Manufacturing He joins the firm with more than 28 years of biopharmaceutical manufacturing experience Chris Kilbee appointed Group Director of UBM Pharma Portfolio Chris Kilbee appointed Group Director of UBM Pharma Portfolio Aims to expand the portfolio globally, putting increased emphasis on digital and content SCM Pharma appoints US business development manager SCM Pharma appoints US business development manager Derek Richards takes up the role Merck Serono appoints Steven Hildemann as Global Chief Medical Officer Merck Serono appoints Steven Hildemann as Global Chief Medical Officer He brings more than 20 years of experience to Merck Serono, across academic medicine and the pharmaceutical industry TiGenix appoints Gri-Cel CEO and COO to Board of Directors TiGenix appoints Gri-Cel CEO and COO to Board of Directors Following strategic investment of EUR12m by Grifols Sitka Biopharma appoints Sean Cunliffe as Chief Executive Sitka Biopharma appoints Sean Cunliffe as Chief Executive Canadian biotechnology firm is developing a treatment for bladder cancer Richard Sachse takes Chief Scientific Officer role at Aeterna Zentaris Richard Sachse takes Chief Scientific Officer role at Aeterna Zentaris Takes responsibility for all global research and development activities at the Canadian firm John van der Valk appointed MD of UBM Live Amsterdam John van der Valk appointed MD of UBM Live Amsterdam Takes responsibility for overseeing the company’s CPhI brand Kemal Malik joins Bayer Board of Management and takes responsibility for Innovation Kemal Malik joins Bayer Board of Management and takes responsibility for Innovation Professor Wolfgang Plischke will retire on 30 April Nuevolution appoints Ton Berkien as Chief Business Officer Nuevolution appoints Ton Berkien as Chief Business Officer He will lead the commercial and business development efforts of the Copenhagen-based firm Celerion appoints John Horkulak as Executive Director, Eurasian Site Operations Celerion appoints John Horkulak as Executive Director, Eurasian Site Operations Will help expand early phase patient capabilities in Europe and Asia Lorus Therapeutics completes new executive management team Lorus Therapeutics completes new executive management team Avanish Vellanki and Gregory Chow join Canadian biopharmaceutical company as Chief Business Officer and Chief Financial Officer Aptuit names Jonathan Goldman as Chief Executive Aptuit names Jonathan Goldman as Chief Executive He joins the firm from global contract research organisation ICON Clinical Research